11:53 AM EDT, 05/15/2024 (MT Newswires) -- Pacific Biosciences of California ( PACB ) and Ambry Genetics said Wednesday they were selected by the University of California, Irvine, and the Genomics Research to Elucidate the Genetics of Rare diseases Consortium to sequence and analyze up to 7,000 human whole genomes over three years.

The project is aimed at supporting the Pediatric Mendelian Genomics Research Center program to better understand the underlying biology of rare diseases, according to the companies.

The collaboration will use long-read sequencing technology to conduct phenotyping, identify variants, and analyze alterations, the companies said. Financial details weren't provided.

Pacific Biosciences shares were down 3.6% in recent trading.

Price: 2.15, Change: -0.08, Percent Change: -3.63